Akebia Therapeutics
AKBA
₹163.68
Share price
-1.04%
Change (1 day)
20.43%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : ₹23.12 Billion
According to Akebia Therapeutics's latest financial reports the company's total liabilities are ₹23.12 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Akebia Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹23.14 B | 2.13% |
| 2023-12-31 | ₹22.66 B | -21.92% |
| 2022-12-31 | ₹29.03 B | -14.34% |
| 2021-12-31 | ₹33.89 B | 16.87% |
| 2020-12-31 | ₹28.99 B | 8.03% |
| 2019-12-31 | ₹26.84 B | 6.46% |
| 2018-12-31 | ₹25.21 B | 63.4% |
| 2017-12-31 | ₹15.43 B | -2.16% |
| 2016-12-31 | ₹15.77 B | 1887.39% |
| 2015-12-31 | ₹0.79 B | 81.03% |
| 2014-12-31 | ₹0.43 B | 81.48% |
| 2013-12-31 | ₹0.24 B | -10.39% |
| 2012-12-31 | ₹0.26 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹7.366 T | 31,754.89% | 🇺🇸 USA |
 | ₹4.980 T | 21,437.49% | 🇨🇭 Switzerland |
 | ₹9.307 T | 40,149.02% | 🇺🇸 USA |
 | ₹20.83 B | -9.91% | 🇺🇸 USA |